Roivant Sciences Ltd.
Roivant Sciences Ltd. (ROIV) — Form 144: Proposed sale of shares
AI-generated summary
Officer Eric Venker proposed to sell 200,000 common shares of Roivant Sciences Ltd. with an aggregate market value of $7,262,568 through Rockefeller Financial LLC. The proposed sale date is November 3, 2026. The transaction will be made under a Rule 10b5-1 trading plan adopted on June 30, 2026.
Key facts
- Seller
- Venker Eric
- Relationship
- Officer
- Shares to sell
- 200,000
- Market value
- $7,262,568.00
- Approximate sale date
- Nov 3, 2026
- Broker
- Rockefeller Financial LLC
- Acquired (1)
- Mar 20, 2025 · Options Exercise - Grant Date 04/20/2022
- Acquired (2)
- Apr 20, 2023 · RSU Grant 018305 - Grant date 05/20/2020
- Acquired (3)
- May 20, 2023 · RSU Grant 018305 - Grant date 05/20/2020
- Acquired (4)
- Jun 20, 2023 · RSU Grant 018305 - Grant date 05/20/2020
- Acquired (5)
- Dec 20, 2024 · RSU Grant 018861 - Grant date 05/20/2021
- Acquired (6)
- Dec 20, 2024 · RSU Grant 018861 - Grant date 05/20/2021
- Acquired (7)
- Jun 3, 2025 · Options Exercise - Grant Date 04/20/2022
- Acquired (8)
- Sep 19, 2025 · Options Exercise - Grant Date 04/20/2022
- Acquired (9)
- Jun 2, 2025 · Options Exercise - Grant Date 04/20/2022
Rule 10b5-1 plan · adopted Jun 30, 2026
Remarks
- The shares reported on this Form 144 will be sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 06/30/2026.
More ROIV filings
- 4
Filed Oct 30, 2026
- 144
Filed Oct 28, 2026
- 4
Filed Oct 27, 2026
- 4
Filed Oct 27, 2026
- 4
Filed Oct 27, 2026
- SC 13G/A
Filed Oct 27, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.